pharma · Hypertension · Gastric Ulcer
Yung Shin Pharmaceutical
Yung NA
Yung Shin Pharmaceutical trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Taichung, CN
- Founded
- 1952
- Employees
- 264
- Programs
- 10
- Drugs
- 13
- Patents
- 0
Yung Shin Pharmaceutical clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Yung Shin Pharmaceutical programs — each row shows trial ID, program name, phase, status, and indication.
Yung Shin Pharmaceutical trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Yung Shin Pharmaceutical.
-
Rabeprazole Sodium 10mg — Phase 1
Clinical update -
Prednisone + Jakavi(ruxolitinib) — Phase 2
Clinical update -
Fimasartan/Atorvastatin Combination Tablet — Phase 1
Clinical update -
Fimasartan and Rosuvastatin — Phase 3
Clinical update -
dabigatran — Phase 3
Clinical update -
gemcitabine — Phase 2
Clinical update -
BRI-1501 — Phase 1
Clinical update -
Fimasartan — Phase 1
Clinical update